VeriStrat can help your physician make a more informed decision about your treatment options.
VeriStrat is a simple blood test that your physician may order to help determine if you are likely to benefit from a specific lung cancer therapy, called Tarceva®. Upon receipt of the test results, your physician will consider them, and other factors,to make the most appropriate treatment plan for you.
Below are the questions most frequently asked by patients and caregivers regarding VeriStrat. If you have additional questions, please be sure to talk to your physician.
What is VeriStrat?
VeriStrat is a blood test for patients with advanced NSCLC. VeriStrat provides a test result of either VeriStrat Good or VeriStrat Poor. A VeriStrat Good test result is associated with better outcomes for patients treated with Tarceva® than a VeriStrat Poor test result. This information will help your physician make a more informed decision about your treatment plan.
Occasionally a test result will be reported as VeriStrat Indeterminate. If you receive an Indeterminate result, your doctor may or may not decide to reorder the test.
Why should I have the VeriStrat test done?
VeriStrat provides information that will help your physician make a more informed decision about your treatment plan. The test, along with other clinical factors, will help your physician determine if you should receive a lung cancer treatment called Tarceva® (or erlotinib).
How is the VeriStrat test performed?
The VeriStrat test requires you to provide a small amount of blood, which is drawn quickly and easily. Your blood sample is centrifuged and the resulting serum is shipped to our central laboratory for proteomic analysis by mass spectrometry. Results are typically provided to your doctor within 72 hours of the serum shipment.
Where can I get more information about the VeriStrat test?
Talk to your physician about any questions you may have regarding the VeriStrat test. In addition, you can speak with a customer service representative by calling the VeriStrat Support Hotline at 866-432-5930.
Tarceva is a registered trademark of OSI Pharmaceuticals
